{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:28:01Z","timestamp":1776954481344,"version":"3.51.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/ndt\/gfu209","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T04:16:51Z","timestamp":1402546611000},"page":"2084-2091","source":"Crossref","is-referenced-by-count":60,"title":["Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance"],"prefix":"10.1093","volume":"29","author":[{"given":"Jo\u00eblle","family":"Guitard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Hebral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Fakhouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Daugas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Rivalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Guigonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7is","family":"Ducret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Presne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Pirson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryvonne","family":"Hourmant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Glachant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Moranne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislas","family":"Faguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"key\n\t\t\t\t20170518092620_GFU209C1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170518092620_GFU209C2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170518092620_GFU209C3","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-013-0415-3","article-title":"Immunopathogenesis of idiopathic nephrotic syndrome with relapse","author":"Sahali","year":"2014","journal-title":"Semin Immunopathol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C4","doi-asserted-by":"crossref","first-page":"ra39","DOI":"10.1126\/scisignal.2000678","article-title":"c-mip impairs podocyte proximal signaling and induces heavy proteinuria","volume":"3","author":"Zhang","year":"2010","journal-title":"Sci Signal"},{"key":"key\n\t\t\t\t20170518092620_GFU209C5","doi-asserted-by":"crossref","first-page":"e30523","DOI":"10.1371\/journal.pone.0030523","article-title":"Upregulation of nuclear factor-related kappa B suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome","volume":"7","author":"Audard","year":"2012","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170518092620_GFU209C6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170518092620_GFU209C7","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","article-title":"Rituximab therapy for steroid-dependent minimal change nephrotic syndrome","volume":"21","author":"Gilbert","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00467-012-2319-1","article-title":"Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome","volume":"28","author":"Ito","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00467-012-2406-3","article-title":"Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome","volume":"28","author":"Tellier","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518092620_GFU209C11","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","article-title":"Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome","volume":"27","author":"Kemper","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092620_GFU209C12","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","article-title":"Rituximab in children with resistant idiopathic nephrotic syndrome","volume":"23","author":"Magnasco","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","article-title":"Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations","volume":"49","author":"Fran\u00e7ois","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518092620_GFU209C14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ndt\/gft312","article-title":"Rituximab for minimal change disease in adults: long-term follow-up","volume":"29","author":"Bruchfeld","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092620_GFU209C15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10157-011-0510-5","article-title":"Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome","volume":"15","author":"Amemiya","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","article-title":"Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease","volume":"83","author":"Munyentwali","year":"2013","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518092620_GFU209C17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","article-title":"Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases","volume":"23","author":"Guigonis","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C18","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C19","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C20","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","author":"Ruggenenti","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C21","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170518092620_GFU209C22","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/TP.0b013e3181735723","article-title":"B cell survival in intragraft tertiary lymphoid organs after rituximab therapy","volume":"85","author":"Thaunat","year":"2008","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20170518092620_GFU209C23","doi-asserted-by":"crossref","first-page":"c98","DOI":"10.1159\/000319656","article-title":"Effect of single-dose rituximab on primary glomerular diseases","volume":"117","author":"Sugiura","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170518092620_GFU209C24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00467-006-0427-5","article-title":"Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?","volume":"22","author":"Smith","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","article-title":"Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine","volume":"25","author":"Fujinaga","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170518092620_GFU209C26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ndt\/gfs515","article-title":"Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults","volume":"28","author":"Takei","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092620_GFU209C27","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/29\/11\/2084\/12867197\/gfu209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T04:48:50Z","timestamp":1503550130000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfu209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,6,11]]},"published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfu209","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}